Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2000
12/28/2000CA2376284A1 A method for the prophylaxis and/or treatment of medical disorders
12/28/2000CA2376081A1 Cysteinyl protease inhibitors
12/28/2000CA2375869A1 Regulation system of expression using nuclear ppar receptors
12/28/2000CA2375781A1 Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abci
12/28/2000CA2375771A1 Nucleic and proteinic acids corresponding to human gen abc1
12/28/2000CA2375527A1 Method for enhancing hematopoiesis
12/28/2000CA2375508A1 Methods and products for manipulating uncoupling protein expression
12/28/2000CA2375502A1 Novel pyrrhocoricin-derived peptides, and methods of use thereof
12/28/2000CA2375498A1 Epithelial cell growth inhibitors
12/28/2000CA2375493A1 Human transport proteins
12/28/2000CA2375477A1 Novel calpains and their use
12/28/2000CA2375475A1 Serin proteinase inhibitors
12/28/2000CA2375414A1 Human transcriptional regulator proteins
12/28/2000CA2375407A1 Rna metabolism proteins
12/28/2000CA2375229A1 Method and compounds for inhibiting activity of serine elastases
12/28/2000CA2375207A1 Peptide having preptin functionality
12/28/2000CA2374270A1 Labeled neurotensin derivatives
12/28/2000CA2373391A1 Spheroid preparation
12/28/2000CA2371924A1 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
12/28/2000CA2368099A1 Adenosine diphosphatase and activators thereof and their medical uses
12/28/2000CA2349865A1 Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat metabolic instability associated with non-insulin dependent diabetes
12/28/2000CA2345350A1 Agent for regulating iodine exchange or for preventing iodine-deficit conditions
12/28/2000CA2276542A1 Novel peptide, a method for its preparation and a pharmaceutical composition containing the peptide
12/27/2000EP1063296A1 Nucleic acid enzyme showing allosteric rna-cleaving activity on target rna
12/27/2000EP1063294A1 Dnas or genes participating in parkinson's disease
12/27/2000EP1063293A2 Transforming growth factor alpha H1
12/27/2000EP1063292A2 DNA encoding human alpha 1 adrenergic receptors and uses thereof
12/27/2000EP1063291A2 DNA encoding human alpha 1 adrenergic receptors and uses thereof
12/27/2000EP1063254A1 Copolymers for the transport of nucleic acids in the cell
12/27/2000EP1062953A1 Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke
12/27/2000EP1062949A1 IgE ANTIBODY PRODUCTION INHIBITORS AND AUTOIMMUNE DISEASES INHIBITORS
12/27/2000EP1062879A1 Aqueous solution for the parenteral nutrition
12/27/2000EP1062876A1 Caseinoglycomacropeptides as calcification agent
12/27/2000EP1062509A2 Methods and compositions for diagnosis of rheumatoid arthritis
12/27/2000EP1062349A2 Diisopropyl fluorophosphatase and the utilization and production thereof
12/27/2000EP1062348A1 Recombinant onconase, and chemical conjugates and fusion proteins of recombinant onconase
12/27/2000EP1062347A1 Diagnostics and vaccines for mycobacterial infections of animals and humans
12/27/2000EP1062341A1 Mutant recombinant allergens
12/27/2000EP1062340A2 Compositions and methods for the treatment and prevention of metastatic disorders
12/27/2000EP1062339A2 Human fgf gene and gene expression products
12/27/2000EP1062338A2 Human membrane spanning proteins
12/27/2000EP1062337A1 Human n-type calcium channel isoform and uses thereof
12/27/2000EP1062336A1 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
12/27/2000EP1062335A1 Breast cancer antigen
12/27/2000EP1062334A1 Mammalian sodium channel proteins
12/27/2000EP1062332A2 Human receptor proteins; related reagents and methods
12/27/2000EP1062331A1 Compounds related to pap-1
12/27/2000EP1062330A2 Ribozymes capable of inhibiting the expression of the ccr5 receptor
12/27/2000EP1062328A1 Suicide gene therapy system for the treatment of brain tumours
12/27/2000EP1062326A1 Glycosyl sulfotransferase-3
12/27/2000EP1062323A2 Methods of diagnosis and triage using cell activation measures
12/27/2000EP1062320A1 Methods and compositions for the selective expansion of gamma/delta t-cells
12/27/2000EP1062319A1 Vascular endothelial growth factor 2
12/27/2000EP1062246A1 Anti-inositolphosphoglycan monoclonal antibodies
12/27/2000EP1062243A2 Controlling availability or activity of proteins by use of protease inhibitors or receptor fragments
12/27/2000EP1062242A1 Human g-protein coupled receptor (gpr25)
12/27/2000EP1062240A1 N-terminally modified glp-1 derivatives
12/27/2000EP1062239A2 Ribonucleotide polypeptides containing metal
12/27/2000EP1062238A1 Ecr673: a 7-transmembrane g-protein coupled receptor
12/27/2000EP1062237A1 Ribonucleotide polypeptides containing metal
12/27/2000EP1062236A1 31 human secreted proteins
12/27/2000EP1062234A2 Mammalian blood loss-induced gene, kd312
12/27/2000EP1062233A1 Secreted proteins and polynucleotides encoding them
12/27/2000EP1062232A2 Molecules that home to various selected organs or tissues
12/27/2000EP1062230A1 Method for increasing the serum half-life of a biologically active molecule
12/27/2000EP1062229A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
12/27/2000EP1062228A1 Plasminogen-related gene b polypeptides
12/27/2000EP1062226A1 High affinity nucleic acid ligands of complement system proteins
12/27/2000EP1062225A1 REPLICATIVE HELICASE dnaB OF $i(STAPHYLOCOCCUS AUREUS)
12/27/2000EP1062224A1 Modified factor viii
12/27/2000EP1061963A1 Protease inhibitors in absorbent articles
12/27/2000EP1061962A1 Disposable absorbent article having a skin care composition containing an enzyme inhibitor
12/27/2000EP1061948A1 Sustained-release preparation of physiologically active polypeptide and production thereof
12/27/2000EP1061947A1 Stabilized aqueous peptide solutions
12/27/2000EP1061946A1 Glp-1 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates
12/27/2000EP1061945A1 Use of vip analogues for preventing and treating brain damage in human babies
12/27/2000EP1061944A2 Therapeutic chemokine receptor antagonists
12/27/2000EP1061943A1 Method of preventing the death of retinal neurons and treating ocular diseases
12/27/2000EP1061942A1 Topical composition containing human epidermal growth factor
12/27/2000EP1061941A2 A pharmaceutical composition containing ezrin mutated on tyrosine 353
12/27/2000EP1061940A2 Use of follistatin to modulate gdf-8 and bmp-11
12/27/2000EP1061939A1 Recombinant fibronectin-based extracellular matrix for wound healing
12/27/2000EP1061938A1 Oral compositions at low dosage of cytotoxic proteins
12/27/2000EP1061937A1 Improved radiation therapy methods
12/27/2000EP1061936A1 Cyclic dipeptides and azetidinone compounds and their use in treating cns injury and neurodegenerative disorders
12/27/2000EP1061935A1 Proapoptotic peptides, dependence polypeptides and methods of use
12/27/2000EP1061933A1 Fibronectin peptides-based extracellular matrix for wound healing
12/27/2000EP1061931A2 Thrombin preparation and products and fibrin sealant methods employing same
12/27/2000EP1061917A1 Methods of inhibiting bone resorption
12/27/2000EP1061908A1 Combination therapy and composition for acute coronary ischemic syndrome and related conditions
12/27/2000EP1061902A1 Colonic delivery of protein or peptide compositions
12/27/2000EP1061897A1 Glycylglycine oleamide in dermo-cosmetology
12/27/2000EP1061887A1 Novel use of phospholipids of vegetable and animal origin in nutritional therapy
12/27/2000EP1061873A1 Use of corneal hardening agents in enzyme orthokeratology
12/27/2000EP1061805A1 Regulation of endogenous gene expression in cells using zinc finger proteins
12/27/2000EP1061800A1 Compositions and methods for modulating vascularization
12/27/2000EP0832214B1 Oligonucleotides specific for human papillomavirus
12/27/2000EP0804483B1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules
12/27/2000EP0793472A4 Method of using lectins for agglutination and collection of menstrual flow
12/27/2000EP0791065B1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules
1 ... 2309 2310 2311 2312 2313 2314 2315 2316 2317 2318 2319 2320 2321 2322 2323 2324 2325 2326 2327 2328 2329 ... 3163